Sections Show

Nathanson Lab

ONCOLOGY/SIGNAL TRANSDUCTION/MOLECULAR IMAGING

The Nathanson Lab focuses on malignant gliomas, some of the most lethal of all cancers. Using a suite of tools, including innovative molecularly characterized patient-derived orthotopic glioma xenografts (PDOX), molecular imaging (e.g., PET imaging), and nanotechnology for interrogating single cells, our lab has a specific interest in investigating the dynamic interplay between specific genetic alterations and critical functional processes (e.g., signaling, apoptosis, metabolism) in malignant gliomas. Through close collaborations with UCLA Neuro-Oncology, UCLA Chemistry, and Caltech, our ultimate goal is to develop new therapeutic strategies that can be translated into improved outcomes for patients with malignant brain cancer.   

NEWS: Our graduate student Wilson Mai just published his paper “Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma” in Nature Medicine. Read more here…

documents_whiteClick here for full publication list

 

Explore the lab

The Team
Featured Publications
Filter By:
All
Clinical
Translational
Radiochemistry
Sort by:
A to Z
Date
Featured

 

Copyright UCLA

site design + code by ONE LONG HOUSE

Contact Us